基本介紹
- 中文名：周也荻
- 學位/學歷：博士
- 職業：教師
- 專業方向：臨床醫學
- 任職院校：中南大學
個人經歷,研究方向,學術成果,
個人經歷
教育經歷
[1]2013.4-2016.9
日本九州大學| 眼科學| 博士學位| 博士研究生畢業
[2]2012.10-2013.3
日本九州大學| 眼科學| Research Student| 研究生（博士預科）
[3]2011.9-2012.9
中南大學| 眼科學| Master student| 碩士研究生（期間出國留學）
[4]2006.9-2011.6
中南大學| 臨床醫學| 學士學位| 大學本科畢業
工作經歷
[1]2016.10-至今
眼科| 中南大學湘雅二醫院 助理研究員/醫師
社會兼職
- [1]湖南省醫學會眼科學專業委員會神經眼科和眼病理學組秘書兼職時間：2019/12/01 --至今
- [2]中國研究型醫院學會神經眼科專業委員會青年委員兼職時間：2019/07/01 --至今
- [3]日本眼科學會會員兼職時間：2015/12/01 --至今
- [4]《臨床與病理雜誌》中青年編委兼職時間：2018/02/01 --至今
研究方向
- [1] 視網膜/脈絡膜新生血管性疾病
- [2] 眼免疫學
- [3] 視神經疾病
學術成果
論文成果
[1] Jia Y, Zhou Y*（通訊作者）. Involvement of lncRNAs and macrophages: potential regulatory link to angiogenesis [J]. J Immunol Res, 2020,
[2] Liu X, Zhang L, Wang JH, Zeng H, Zou J, Tan W, Zhao H, He Y, Shi J, Yoshida S, Li Y, Zhou Y*（通訊作者）. Investigation of circRNA Expression Profiles and Analysis of circRNA-miRNA-mRNA Networks in an Animal (Mouse) Model of Age-Related Macular Degeneration. [J]. Cur Eye Res, 2020,
[3] Zhang L, Zeng H, Wang JH, Zhao H, Zhang B, Zou J, Yoshida S, Zhou Y*（通訊作者）. Altered Long Non-coding RNAs Involved in Immunological Regulation and Associated with Choroidal Neovascularization in Mice [J]. Int J Med Sci, 2020,
[4] Cao M, Zhang L, Wang JH, Zeng H, Peng Y, Zou J, Shi J, Zhang L, Li Y, Yoshida S, Tang L, Zhou Y*(通訊). Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice [J]. Int J Med Sci, 2019,
[5] Zhang L, Liu S, Wang JH, Zou J, Zeng H, Zhao H, Zhang B, He Y, Shi J, Yoshida S, Zhou Y* （通訊作者）. Differential expressions of microRNAs and transfer RNA-derived small RNAs: potential targets of choroidal neovascularization [J]. Current Eye Research, 2019,
[6] Zhang LS#, Zhou YD#（並列一作）, Peng YQ, Zeng HL, Yoshida S, Zhao TT.. Identification of altered microRNAs in retinas of mice with oxygen-induced retinopathy [J]. Int J Ophthalmol, 2019,
[7] Zhang L#, Fu X#, Zeng H, Wang JH, Peng Y, Zhao H, Zou J, Zhang L, Li Y, Yoshida S, Zhou Y*（通訊作者）. Microarray Analysis of Long Non-Coding RNAs and Messenger RNAs in a Mouse Model of Oxygen-Induced Retinopathy [J]. Int J Med Sci, 2019, 16(4): 537-547
[8] Li Y, Zhou Y*(通訊作者). Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases [J]. Tohoku J Exp Med, 2019,
[9] Peng Y#, Cao M#, Yoshida S,Zhang L,Zeng H, Zou J,Kobayashi Y,Nakama T, Shi J, Jia S, Zhou Y*(通訊作者). Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ [J]. Int J Ophthalmol, 2019,
[10] Zhou YD*, Yoshida S*, Peng YQ, Kobayashi Y, Zhang LS, Tang LS. Diverse roles of macrophages in intraocular neovascular diseases: a review [J]. Int J Ophthalmol, 2017,
[11] Zhou Y, Yoshida S*, Kubo Y, Yoshimura T, Kobayashi Y, et al. Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization [J]. Mol Med Rep, 2017,
[12] Zhou Y, Yoshida S*, Kubo, Y, Kobayashi Y, Nakama T, et al.. Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy [J]. Sci Rep, 2016,
[13] Zhou Y, Yoshida S*, Nakao S, Yoshimura T, Kobayashi Y, et al.. M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy [J]. Invest Ophthalmol Vis Sci, 2015,
[14] Peng Y, Tang L, Zhou Y* (通訊作者). Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases. [J]. Ophthalmic Res, 2017,
[15] Peng Y#, Zhao Y#, Hu W, Hu Y, He Y, Zhou Y* (通訊作者). Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis [J]. Clin Neurol Neurosurg, 2017,
[16] Peng YQ, Tang LS, Yoshida S, Zhou YD* (通訊作者). Applications of CRISPR/Cas9 in Retinal Degenerative Diseases [J]. Int J Ophthalmol, 2017,
[17] Zhang L, Liang Y, Zhou Y, Zeng H, Jia S*, Shi J*. A Missense Mutation in GJA8 Encoding Connexin 50 in a Chinese Pedigree with Autosomal Dominant Congenital Cataract. [J]. Tohoku J Exp Med, 2018,
[18] Wada I, Yoshida S*, Kobayashi Y, Zhou Y, Ishikawa K, et al. Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole. [J]. Clin Ophthalmol, 2017,
[19] Nakama T, Yoshida S*, Ishikawa K, Kubo Y, Kobayashi Y, Zhou Y, et al.. Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. [J]. Mol Ther Nucleic Acids, 2017,
[20] Wang JH, Wang R, Lee JH, Iao TWU, Hu X, et al.. Public Attitudes toward Gene Therapy in China. [J]. Mol Ther Methods Clin Dev, 2017,
[21] Kobayashi Y, Yoshida S*, Zhou Y, Nakama T, Ishikawa K, et al.. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. [J]. Mol Vis, 2016,
[22] Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, et al.. Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV. [J]. Lab Invest, 2016,
[23] Yamaguchi M, Nakao S*, Arita R, Kaizu Y, Arima M, Zhou Y, et al.. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia. [J]. Invest Ophthalmol Vis Sci, 2016,
[24] Ishikawa K, Yoshida S*, Kobayashi Y, Zhou Y, Nakama T, et al.. Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy. [J]. Invest Ophthalmol Vis Sci, 2015,
[25] Yoshida S*, Kubo Y, Kobayashi Y, Zhou Y, Nakama T, et al.. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular edema. [J]. Br J Ophthalmol, 2015,
[26] Yoshida S, Kobayashi Y, Nakama T, Zhou Y, Ishikawa K, et al.. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: Implications for M2 macrophage-involving fibrovascular membrane formation. [J]. Br J Ophthalmol, 2015,
[27] Kobayashi Y, Yoshida S*, Nakama T, Zhou Y, Ishikawa K, et al.. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: Possible involvement of periostin. [J]. Br J Ophthalmol, 2015,
[28] Nakama T, Yoshida S*, Ishikawa K, Kobayashi Y, Zhou Y, et al.. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. [J]. Gene Ther, 2015.
科研項目
[3]干擾素γ誘導巨噬細胞M1極化調控視網膜新生血管的作用和機制
專利成果
[1]一種動物實驗用密閉倉
[2]一種定量定位的扣蓋式滴眼藥水瓶
[3]一種瞼板腺按摩器
